Aetna policies
Search Aetna's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
Checking prior authorization for 36514? Open Aetna’s official lists and confirm the member’s product there.
6 policies name 36514, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0949-Caplacizumab-yhdp (Cablivi) | 0949 · Commercial | 10 | Original policy ↗ |
| 0285-Plasmapheresis/Plasma Exchange/Therapeutic Apheresis | 0285 · Commercial | 37 | Original policy ↗ |
| 1002-Efgartigimod Alfa-fcab (Vyvgart) and Efgartigimod Alfa and Hyaluronidase-qvfc (Vyvgart Hytrulo) | 1002 · Commercial | 42 | Original policy ↗ |
| 0732-Guillain-Barre Syndrome Treatments | 0732 · Commercial | 43 | Original policy ↗ |
| 0788-Alzheimer's Disease: Experimental, Investigational, or Unproven Treatment | 0788 · Commercial | 95 | Original policy ↗ |
| Multiple Sclerosis | 0264 · Commercial | 126 | Original policy ↗ |